Clinical Trial Update: Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating the concomitant use of rifampicin and efavirenz for TB and HIV co-infection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• EFAVIRENZ (efavirenz)
• Rifampicin

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: Tuberculosis, HIV Infections | Phase 4 | Status: TERMINATED